Engineered nucleic acids and methods of use thereof for non-human vertebrates
AssigneeModerna Therapeutics, Inc.
InventorsNoubar B. Afeyan, Gregory J. Sieczkiewicz, Stephane Bancel
Life of this patent
Estimating the term…
Abstract
Provided are formulations, compositions, kits and methods for delivering biological moieties such as modified nucleic acids into cells to induce, reduce or modulate protein expression in non-human vertebrates.
Claims20
A method of producing a polypeptide of interest in a cell, tissue or bodily fluid of a non-human vertebrate subject in need thereof comprising administering to said subject a pharmaceutical composition comprising a nucleic acid encoding said polypeptide of interest.
A kit for producing a first polypeptide of interest in a cell, tissue or bodily fluid of a non-human vertebrate subject in need thereof comprising a first nucleic acid encoding said first polypeptide of interest.
Dependencies are inferred from the claim text.